Skip to main content
. 2021 May 6;9(5):467. doi: 10.3390/vaccines9050467
PRISMA The Preferred Reporting Items for Systematic Reviews and Meta-Analyses Statement
MeSH Medical subject headings
WHO World Health Organization
CDC Center for Disease Control
RCT Randomized clinical trial
COVID-19 Coronavirus disease 2019
alum Potassium aluminum sulfate
VLPs Virus-like particles
ORs Odds ratios
6-HB six-helical bundle
SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2
95% CI 95% confidence interval
GMT Geometric mean titer
RBD Receptor-binding domain
PLpro Papain-like proteases
3CLpro Cysteine-like protease
NAb Neutralizing antibody
Pro-subunit Protein subunit
VLP Virus-like particle
BMI Body mass index
CFR Case fatality ratio
RNA Ribonucleic acid
messenger RNA mRNA
S-protein Spike protein
ACE2 Angiotensin-converting enzyme 2
nsp Non-structural proteins
IM Intramuscular